Unstructured Finance

Investors worry about Towers Watson

June 29, 2009

Watson Wyatt and Towers Perrin executives are excited about their deal to create Towers Watson, but investors are not cheering as much. 

No bruised egos as Bharti-MTN redial once again

May 25, 2009

Exactly one year ago, squabbles over control forced Bharti Airtel and MTN to ditch their hope of forming a global telecoms group, but both emerging markets-focused companies are back on the negotiating table to thrash out a $61 billion merger.

The clock is ticking for BankUnited

May 21, 2009

Florida condominiumsSome people thought Florida lender BankUnited would be sold months ago as regulators fretted over its health amid the housing downturn. 

Big car. Smaller and smaller offers.

April 9, 2009

HummerThe number of bidders for GM’s Hummer brand has narrowed down to three, with current offers ranging from $100 million to $200 million in cash, in addition to other commitments, sources told Reuters.

Missing Lady Luck

April 7, 2009

CityCenterThere was a time not so long ago when “smart” investors and analysts believed that casinos were a sure bet, that gambling was recession proof, and that it was a vice people could not shake off even if money got tight. And so casino giant after casino giant started on mega projects that set to outdo each other and make glitzy Las Vegas, well, glitzier. 

Citi: No need for more aid

March 13, 2009

Richard ParsonsCitigroup, which has received $45 billion of U.S. government funds since October, may have had its fill of taxpayer money.

Credit crisis advantage?

January 30, 2009

RocheThe credit crisis may just be the leverage Roche needs in its bid for Genentech.

The Swiss drug maker went hostile with its bid to buy the 44 percent of Genentech it doesn’t already own. But in a rather unusual move, it has gone to shareholders with an offer that is actually lower than the $44 billion bid it initially made for the U.S. biotech group.

Plane talk

January 28, 2009

CitibankCiti scrapped plans to buy a $50 million corporate jet after it raised eyebrows all the way to the White House. Politicians called the order, which was made in 2005, wasteful. 

A trigger for more drug deals?

January 26, 2009

Jeff KindlerPfizer has taken the plunge, and others may follow.

The world’s largest drug maker is buying rival Wyeth for $68 billion in cash and stock to become even larger.  

Pfizer: Dealing with Lipitor side-effects

January 23, 2009

Pfizer’s at it again. The world’s largest drugmaker by revenue has set its sights on rival Wyeth and the two are talking about a deal that could be valued at more than $60 billion, according to the Wall Street Journal.